Trial Lawyer View Blog

Trial Lawyer View, the go-to podcast for personal injury trial lawyers. Hosted by Jason D. Lazarus, a renowned attorney expert to fellow lawyers and author of The Art of Settlement & Litigation to Life. The podcast explores cutting-edge topics in personal injury law, covering best practices, firm growth strategies, and ways to accelerate success. As part of Peak Practice by Synergy, a community dedicated to helping to optimize personal injury practices, the podcast also delves into firm operations, marketing, technology, and more

So you committed malpractice …

Q. I’m not inclined to make excuses. But things have been so hectic in my office that I let a nice accident case slip through the cracks and failed to file suit by the limitations deadline. My head is spinning. What should …

Read Post

Suspending an “Extreme” Sanction

Finding Bar Counsel’s call for an indefinite suspension too “extreme,” the Court imposed a more modest moratorium on a lawyer with an unblemished record in close to 50 years of practice. Issue: What sanction should the Court impose upon an …

Read Post

Online Review Rebuttals

Q. My online reputation is everything to me. So how should I respond to a scathing review that called me an “awful” and “dishonest lawyer” who cares more about money than people? A. …

Read Post

Encryption Ethics

Q. After emailing several documents to opposing counsel, she slammed me for failing to encrypt the message and exposing records on her client’s medical history. Must I encrypt these emails? A. There are no …

Read Post

Virtual Arbitration Shopping List

We recently tried our very first Virtual Arbitration. It was such a different experience from being in a courtroom, or even in a conference room. The ease with which we show exhibits and point to demonstratives was replaced by the need for multiple clicks. The ability to show an exhibit

Read Post

Unregulated Stem Cell Therapy Brings More Harm Than Help

In September 2019, the U.S. Food and Drug Administration (FDA) issued a warning to consumers: “Watch out for unapproved stem cell therapies!” The warning comes from the agency in response to the mounting concern of patients seeking cures and pain remedies who are vulnerable to stem cell treatments that are …

Read Post